Avasimibe is an orally bioavailable inhibitor of the acyl coenzyme A: cholesterol acyltransferase (ACAT) (IC₅₀ = 60 nM). Avasimibe a lso inhibits major drug metabolizing enzymes such as CYP2C9 (IC₅₀ = 2.9 µM ), CYP1A2 (IC₅₀ = 13.9 µM), and CYP2C19 (I

Numéro d'article : BIOV9506-5

Unité de mesure : 5 MG

108.00 CHF 108.0 CHF 108.00 CHF

108.00 CHF

Cette combinaison n'existe pas.

AJOUTER AU PANIER

Délai de livraison actuel sur demande

Fabricant : BIOVISION

Numéro du fabricant : 9506-5

Température de stockage : Freezer (-20)

Avasimibe is an orally bioavailable inhibitor of the acyl coenzyme A: cholesterol acyltransferase (ACAT) (IC₅₀ = 60 nM). Avasimibe a lso inhibits major drug metabolizing enzymes such as CYP2C9 (IC₅₀ = 2.9 µM ), CYP1A2 (IC₅₀ = 13.9 µM), and CYP2C19 (I

Avasimibe is an orally bioavailable inhibitor of the acyl coenzyme A: cholesterol acyltransferase (ACAT) (IC₅₀ = 60 nM). Avasimibe a lso inhibits major drug metabolizing enzymes such as CYP2C9 (IC₅₀ = 2.9 µM ), CYP1A2 (IC₅₀ = 13.9 µM), and CYP2C19 (I

108.00 CHF 108.0 CHF 108.00 CHF

108.00 CHF

Not Available For Sale